Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find
"An investigational anti-HIV antibody delivered intravenously once every eight weeks safely and effectively prevented acquisition of HIV strains sensitive to that antibody, but did not significantly...
Read More